http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 20 Jul 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+SAYER+KEVIN+R/26789715.html si-local-file:///var/storage/secattach/20260720/26789715.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+SAYER+KEVIN+R/26789715.html Mon, 20 Jul 2026 16:05:00 -0400 DXCM O.00070687 http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+SAYER+KEVIN+R/26789715.html si-local-file:///var/storage/secattach/20260720/26789715.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+SAYER+KEVIN+R/26789715.html Mon, 20 Jul 2026 16:05:00 -0400 DXCM O.00070687 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DEXCOM+INC++++++++++++++++For%3A+Jul+15++Filed+by%3A+Brown+Michael+Jon/26780498.html si-local-file:///var/storage/secattach/20260716/26780498.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DEXCOM+INC++++++++++++++++For%3A+Jul+15++Filed+by%3A+Brown+Michael+Jon/26780498.html Thu, 16 Jul 2026 17:06:00 -0400 DXCM O.00070687 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DEXCOM+INC++++++++++++++++For%3A+Jul+15++Filed+by%3A+Brown+Michael+Jon/26780498.html si-local-file:///var/storage/secattach/20260716/26780498.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DEXCOM+INC++++++++++++++++For%3A+Jul+15++Filed+by%3A+Brown+Michael+Jon/26780498.html Thu, 16 Jul 2026 17:06:00 -0400 DXCM O.00070687 http://www.streetinsider.com/Analyst+PT+Change/DexCom+%28DXCM%29+PT+Raised+to+%2487+at+Truist+Securities/26776569.html (Updated - July 16, 2026 11:16 AM EDT) <p>Truist Securities analyst Richard Newitter raised the price target on DexCom (NASDAQ: DXCM) to $87.00 (from $80.00) while maintaining a Buy rating.</p><p>The analyst commented, "We're more inclined towards SMIDs where LNTH [Buy], DXCM [Buy], IRTC [Buy] strike us as having both defensive and offensive characteristics - attractive (or not stretched) valuations relative to their growth prospects, offering downside protection if MedTech remains out of favor or gets worse (in LNTH & IRTC's case due to takeout as a floor and DXCM due to somewhat de-risked #'s post the I-day), but can double as http://www.streetinsider.com/Analyst+PT+Change/DexCom+%28DXCM%29+PT+Raised+to+%2487+at+Truist+Securities/26776569.html Thu, 16 Jul 2026 11:16:21 -0400 DXCM http://www.streetinsider.com/Analyst+Comments/DexCom+%28DXCM%29+PT+Raised+to+%2487+at+Truist+Securities/26776569.html (Updated - July 16, 2026 11:16 AM EDT) <p>Truist Securities analyst Richard Newitter raised the price target on DexCom (NASDAQ: DXCM) to $87.00 (from $80.00) while maintaining a Buy rating.</p><p>The analyst commented, "We're more inclined towards SMIDs where LNTH [Buy], DXCM [Buy], IRTC [Buy] strike us as having both defensive and offensive characteristics - attractive (or not stretched) valuations relative to their growth prospects, offering downside protection if MedTech remains out of favor or gets worse (in LNTH & IRTC's case due to takeout as a floor and DXCM due to somewhat de-risked #'s post the I-day), but can double as http://www.streetinsider.com/Analyst+Comments/DexCom+%28DXCM%29+PT+Raised+to+%2487+at+Truist+Securities/26776569.html Thu, 16 Jul 2026 11:16:21 -0400 DXCM http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+Brown+Michael+Jon/26774065.html si-local-file:///var/storage/secattach/20260715/26774065.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+Brown+Michael+Jon/26774065.html Wed, 15 Jul 2026 16:04:00 -0400 DXCM O.00070687 http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+Brown+Michael+Jon/26774065.html si-local-file:///var/storage/secattach/20260715/26774065.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++DEXCOM+INC+++++++++++++++++++++++++++++Filed+by%3A+Brown+Michael+Jon/26774065.html Wed, 15 Jul 2026 16:04:00 -0400 DXCM O.00070687 http://www.streetinsider.com/Analyst+PT+Change/DexCom+%28DXCM%29+PT+Raised+to+%2490+at+Mizuho/26770529.html Mizuho analyst Anthony Petrone raised the price target on DexCom (NASDAQ: DXCM) to $90.00 (from $85.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/DexCom+%28DXCM%29+PT+Raised+to+%2490+at+Mizuho/26770529.html Wed, 15 Jul 2026 06:39:42 -0400 DXCM http://www.streetinsider.com/Corporate+News/Health+Canada+authorizes+Dexcom+G7+15+Day+CGM+for+Canadian+adults/26763009.html <p>Dexcom, Inc. (NASDAQ: DXCM) announced that Health Canada has authorized its Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) system for adults 18 years and older living with diabetes.</p><p>According to the company, the device provides real-time glucose readings for 15.5 days per sensor and carries a mean absolute relative difference (MARD) of 8.0%, which Dexcom claims is best-in-class accuracy compared to competing systems. The longer wear period results in fewer monthly sensor changes relative to the existing Dexcom G7.</p><p>The G7 15 Day retains features from the standard G7, including waterproofing to a depth of eight feet for up to 24 http://www.streetinsider.com/Corporate+News/Health+Canada+authorizes+Dexcom+G7+15+Day+CGM+for+Canadian+adults/26763009.html Mon, 13 Jul 2026 16:46:09 -0400 DXCM http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Press+Releases/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427 http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html <p class="bwalignc"> <i>Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real-time glucose readings for an industry-leading 15.5 days5.</i> </p> <p> BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260713940133/en/" rel="nofollow">https://www.businesswire.com/news/home/20260713940133/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260713940133/en/2850555/4/25.05.26_Dexcom_Day_030483_V2_%281%29.jpg" alt="Dexcom G7 15 Day receives Health Canada authorization. Compatible http://www.streetinsider.com/Business+Wire/Dexcom+G7+15+Day+Receives+Health+Canada+Authorization%3A+Extending+Wear+and+Continuity+for+Canadian+Adults+Living+with+Diabetes/26763004.html Mon, 13 Jul 2026 16:45:00 -0400 A.17150087 A.35426167 A.50212223 DXCM O.00070687 O.00519841 O.34929518 O.50271427